Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines
A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both
Safety and Immunogenicity of MVA85A in Volunteers Latently Infected With TB.
The Safety and Immunogenicity of a TB Vaccine; MVA85A, in Healthy Volunteers Who Are Infected With HIV
A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, With Matrix-M1 Adjuvant
† Study has passed its completion date and status has not been verified in more than two years.